Skip to content
Use caution Drug recall · FDA · Published February 9, 2026

Meitheal Cetrorelix Acetate Injection Kit Recall: Missing or Duplicated Needles

Meitheal Pharmaceuticals recalls Cetrorelix Acetate injection kits with missing or duplicated needles. This could cause injection errors. Return the kit to the pharmacy for a replacement.

🇺🇸 FDA recall #D-0340-2026DrugMeitheal Pharmaceuticals ›
Take action

Contact the company

Recalling firmMeitheal Pharmaceuticals, Inc8700 W Bryn Mawr Ave Ste 600s · Chicago, IL 60631-3529
✎ GovInfoNow plain-language explainer

Meitheal Pharmaceuticals is recalling Cetrorelix Acetate injection kits that may have missing or duplicated needles. This defect could lead to incorrect dosing during medical procedures. Read more at govinfonow.com/recall/31486-meitheal-cetrorelix-acetate-injection-kit-recall-missing-or-duplicated-needles.

Source Summary by GovInfoNow · govinfonow.com/recall/31486-meitheal-cetrorelix-acetate-injection-kit-recall-missing-or-duplicated-needles · Updated August 17, 2026 · FDA enforcement record: FDA #D-0340-2026

Cite this page

“Meitheal Cetrorelix Acetate Injection Kit Recall: Missing or Duplicated Needles.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31486-meitheal-cetrorelix-acetate-injection-kit-recall-missing-or-duplicated-needles. Based on FDA recall #D-0340-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0340-2026%22&limit=1).

Meitheal Pharmaceuticals, Inc. recalled Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, due to a defective delivery system that may result in missing or duplicated needles, the FDA said on Feb. 9, 2026.

How to tell if you have it

  • Brand: Meitheal Pharmaceuticals
  • Product: Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only
  • NDC: 71288-558-90
  • Lot Code: Q4E0112A
  • Expiration Date: 30 Apr 2027
  • Quantity: 16,477 kits

The hazard

The recall addresses a defective delivery system involving missing or duplicated needles within the injection kit. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Meitheal Pharmaceuticals, Inc. has issued two other recalls since Jan. 27, 2021, including a Sept. 3, 2021, recall for failed impurities and a Jan. 27, 2021, recall for label mix-ups. Other recent recalls of similar products include Lupin Ganirelix Acetate Injection (Nov. 13, 2025), Cipla Lanreotide Injection (March 13, 2026), and Reliance Pemetrexed Injection (June 24, 2026).

How to tell if you have this one

Check for the product name 'Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only'. The kit was manufactured by Meitheal Pharmaceuticals in Chicago, IL with NDC 71288-558-90 and lot number Q4E0112A.

  • Brand
    Meitheal Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Kit for Needles

    Inspect the kit for missing or duplicated needles before use.

  2. Contact Pharmacy

    Return the kit to your pharmacy for a replacement.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 9 days after the firm started it.

1. Firm started the recall: Feb 9, 202612. Published in FDA’s Enforcement Report: Feb 18, 202623. FDA classified it Class II: Feb 23, 202632026
  1. Firm started the recall
  2. Published in FDA’s Enforcement Report
  3. FDA classified it Class II

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall indicates a potential defect that could cause incorrect dosing. Do not use the kit until you confirm it's safe with your pharmacy.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0340-2026 (February 9, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0340-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA